FORMYL DASATINIB (25 mg) (N-(2-Chloro-6-methylphenyl)-2-{[6-(4-formyl-1-piperazinyl)-2-methyl-4-pyrimidinyl]amino}-1,3-thiazole-5-carboxamide )

In Stock
Ready to ship

Catalogue No.

1A19690

CAS No.

2112837-79-1

Molecular Formula

C21H22ClN7O2S

Product Type

Pharmaceutical Analytical Impurities

$624.00

Quantity

Click Here to learn more about Pharmaceutical Analytical Impurities (PAI). PAI products are different from official USP Reference Standards. This material is an Analytical Material and not a USP Reference Standard.

Additional information

Current Lot Information

Current Lot:

F301D0

CAS RN®

2112837-79-1

Harmonized System (HS) Code *:

29341000

UN No:

N/A

NDC No:

N/A

Molecular Formula

C21H22ClN7O2S

Container Type:

VIAL

Base Control Substance (substance %):

N | A

Product Information

SDS: Safety data sheet.pdf

USP Certificates/Product Information Sheets and Valid Use Dates

Lot No

USP Certificates/Product Information Sheets and Valid Use Dates

Valid Use Date

Country of Origin*

Material Origin*

F301D0

1A19690-F301D0

See Product Information Sheet

India

Chemical Synthesis

Lot No

F301D0

USP Certificates/Product Information Sheets and Valid Use Dates

1A19690-F301D0

Valid Use Date

See Product Information Sheet

Country of Origin*

India

Material Origin*

Chemical Synthesis

Frequently bought together

FORMYL DASATINIB  (25 mg) (N-(2-Chloro-6-methylphenyl)-2-{[6-(4-formyl-1-piperazinyl)-2-methyl-4-pyrimidinyl]amino}-1,3-thiazole-5-carboxamide  )

Catalogue No.

1A19690

CAS No.

2112837-79-1

Molecular Formula

C21H22ClN7O2S

Product Type

Pharmaceutical Analytical Impurities

OXINDOLE

Catalogue No.

1A09990

CAS No.

59-48-3

Molecular Formula

C8H7NO

Product Type

Pharmaceutical Analytical Impurities

DICLOFENAC ACETAMIDE

Catalogue No.

1A10360

CAS No.

560075-65-2

Molecular Formula

C14H10Cl3NO

Product Type

Pharmaceutical Analytical Impurities